AllPennyStocks.com Monday Action for Firm Using AI in Drug Discovery for Malaria ...

Monday Action for Firm Using AI in Drug Discovery for Malaria Treatment

Monday Action for Firm Using AI in Drug Discovery for Malaria Treatment By: Tomas Ronolski - AllPennyStocks.com News

Monday, January 13, 2025

AI is being used across industries, and its role in drug discovery is pivotal as pharmaceutical companies seek to accelerate the development of new treatments for diseases like malaria and HIV. Through its strategic investment target this company supports the development of cutting-edge AI-powered healthcare solutions.

1606 Corp. (OTC Pink:CBDW) announced in a press release today its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's groundbreaking announcement of Trapicolast. This drug is a pioneering antimalarial drug developed through its innovative AI-powered Sutra™ platform and marks a significant advancement in the fight against malaria, particularly in regions with rising drug resistance.

Trapicolast introduces a novel and highly effective treatment for malaria by focusing on the apicoplast. By targeting its DNA synthesis and vesicular trafficking pathways, Trapicolast disrupts the parasite's ability to survive and reproduce, providing a robust defense against drug-resistant malaria strains.




Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Eli Lilly Milestone and Triple-Digit Growth Outlook Put This Microcap in Focus
Copper-Gold Explorer Gains 12% as IP Maps Chargeability Over 1km
Psychedelic Supplier Climbs 20% After Filament Ships PEX010 Into the EU
Most Popular
{{ index + 1 }}


Back to Top